Skip to main content
Clinical Trials/NCT05760066
NCT05760066
Not yet recruiting
Not Applicable

Effects of Resistance Training Preconditioning on Skeletal Muscle Recovery From a Period of Disuse in Young Adults

Auburn University0 sites24 target enrollmentAugust 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrophy, Disuse
Sponsor
Auburn University
Enrollment
24
Primary Endpoint
Change in quadriceps strength via isokinetic dynamometry
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

The goal of this clinical trial is to compare the effects of resistance training (RT) preconditioning vs no training on disuse-induced atrophy and post-disuse resistance training in young healthy individuals. The main questions it aims to answer are:

  • To determine if performing RT prior to a period of disuse enhances the regain of strength, skeletal muscle size, and skeletal muscle quality while performing RT after a period of disuse.
  • To determine if performing RT prior to a period of disuse dampens the maladaptive effects of disuse on muscle size, muscle quality, and strength.
  • To determine the anabolic and proteolytic mechanisms underpinning the observed outcomes.

Participants will:

  1. Perform either 6 weeks of resistance training or maintain an untrained lifestyle
  2. Perform 2 weeks of limb immobilization induced disuse of a randomized leg
  3. Perform 6 weeks of resistance training

Researchers will compare the resistance training preconditioning condition vs the non-trained condition to see if resistance training prior to a period of disuse is beneficial during the disuse period and in the return to training period on skeletal muscle size, strength, and underpinning molecular markers.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
August 1, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Roberts

Professor

Auburn University

Eligibility Criteria

Inclusion Criteria

  • Between the ages of 18-30
  • Free from medical implants in lower extremity that would interfere with low-dose radiation
  • Are not allergic to ultrasound gel or Lidocaine
  • Have no or minimal experience with resistance training (less than 1 training session/week for a 1 year period)

Exclusion Criteria

  • Have been exposed to medically necessary radiation in the past 12 months other than dental x-rays
  • Have known overt cardiovascular or metabolic disease
  • Have a medical condition that would contraindicate participating in an exercise program or donating a skeletal muscle biopsy (e.g. blood clotting disorder, taking blood thinners, etc.)
  • Are undergoing medical treatment for a disease that would interfere physiologically or logistically with study outcomes and/or protocols (e.g. undergoing chemotherapy and/or radiation for cancer treatment)
  • Have consumed supplemental protein, creatine, and/or agents that affect hormone status (e.g. testosterone, growth hormone boosters, etc.) within the previous 2 months.

Outcomes

Primary Outcomes

Change in quadriceps strength via isokinetic dynamometry

Time Frame: Through completion of study, 16 weeks

Strength of the quadriceps will be assessed via isokinetic dynamometry

Change in vastus lateralis fiber cross-sectional area

Time Frame: Through completion of study, 16 weeks

Upon the procurement and analysis of muscle from the vastus lateralis of participants, histological techniques will be used to assess fiber cross-sectional area of muscle fibers

Change in quadriceps strength via 3 repetition maximum testing

Time Frame: Through completion of study, 16 weeks

Strength of the quadriceps will be assessed via 3-repetition maximum testing of select exercises (leg press, leg extension, hex-bar deadlift)

Secondary Outcomes

  • Change in activity of catabolic systems(Through completion of study, 16 weeks)
  • Gene expression at the mRNA level of atrophy-associated genes (atrogenes)(Through completion of study, 16 weeks)
  • Change in protein expression of anabolic signaling proteins(Through completion of study, 16 weeks)
  • Change in protein expression of catabolic signaling proteins(Through completion of study, 16 weeks)

Similar Trials